October 24, 2019 - "Strong financials driving continued focus on new product opportunities and pipeline progression"
As we prepare to put another year behind us, we look forward to an exciting and promising 2020, filled with opportunities for our lead product on the US market, exciting pipeline advancements and growing our digital health business.
DECEMBER 2, 2019 - Orexo strengthen its competencies within digital health, by appointing Dennis Urbaniak as EVP for Digital Health. Dennis has had a long, successful career within the life sciences industry and during the last years become one of the leading experts in digital health in the US. At Orexo Dennis will have an instrumental role in the work to find innovative digital solutions to improve treatment of addiction.
NOVEMBER 27, 2019 – In line with the ambition to become a leader within treatment of addiction the company today has extended its partnership with GAIA AG by in-licensing of the US commercial rights to vorvida®, a digital therapy for the treatment of Alcohol Use Disorder (AUD). Vorvida® is a fully automated digital therapy with significantly proven efficacy to reduce troublesome drinking patterns in adults with AUD.
Investors, analysts and media are invited to attend our Capital Markets Day that will take place at, Helio GT 30, Grev Turegatan 30, Stockholm, Sweden. The program will start at 1:30 pm CET, with registration from 1:00 pm CET. The event plans to end at 4.00 pm CET. A formal invitation with a complete program will be sent out at a later date. #strategy #pipeline #digitalhealth
➡️The highlights from 2019 and what to expect in 2020➡️Recently our US President, Robert DeLuca presented at DNB´s… hthttps://t.co/xnmnOvRSxR
As we prepare to put another year behind us, we look forward to an exciting and promising 2020, filled with opportu… https://t.co/NVI8Fxe3ck